Fortress Biotech, Inc.·4

Jan 5, 4:30 PM ET

LOBELL J JAY 4

4 · Fortress Biotech, Inc. · Filed Jan 5, 2026

Insider Transaction Report

Form 4
Period: 2026-01-01
LOBELL J JAY
Director
Transactions
  • Award

    common stock, par value $0.001

    2026-01-01+27,322192,397 total
Footnotes (2)
  • [F1]The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.
  • [F2]Total holdings include 76,705 shares underlying deferred restricted stock units.

Documents

1 file
  • 4
    form4-01052026_040120.xmlPrimary